Overview
Shiraz Pharm wholesales medicines for retail and hospital markets, including narcotic and psychotropic medicines. The company handles parallel imports and direct imports under special Ministry of Health permits from the EU, Turkey, Ukraine and India.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 1135 days for 2019).
- 2025not filed
- 202416/03/2026
- 202323/07/2024
- 202208/11/2023
- 202116/12/2022
- 202024/02/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Offer
- Medicines
- Hospital medicines
- Psychotropic medicines
- Narcotic medicines
- Parallel import of medicines
Website technology
- Website
- WordPress
Authorized Representatives
Manner of representation
Two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bogdan Bartkiewiczage 63 | 57 | $769.85 | 51.8182% |
Maciej Jabłońskiage 48 | 11 | $148.57 | 10% |
Nitzan-shdera Management & Promotion Ltd | 24 | $324.15 | 21.8182% |
Łukasz Widarskiage 45 | 11 | $148.57 | 10% |
Others | 7 | $94.54 | 6.3636% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-10-18.
94 1050 1908 1000 0090 3282 5763- 19 1050 1908 1000 0090 3282 5755
- 15 1050 1908 1000 0090 3282 5730
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $475$475 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $597$597 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Trade-Pharmsp. z o.o. | $9,043,325.21 | tradepharm.com.pl | ||
| Pharm Supplysp. z o.o. | $6,901,751.00 | pharmsupply.com.pl | ||
| Inpharmsp. z o.o. + limited partnership | $6,617,533.89 | inpharm.pl | ||
| Polmilsp. z o.o. | $6,332,250.91 | polmil.pl | ||
| Solpharmsp. z o.o. | $6,142,616.88 | solpharm.pl | ||
| Schimarsp. z o.o. + limited partnership | $5,954,367.59 | schimar.pl | ||
| Storkpharmsp. z o.o. | $4,011,334.72 | storkpharm.com | ||
| Inshisp. z o.o. | $2,949,393.06 | inshi.pl | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Pube Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-10-25 | Address change (Ul. Drawska 14/1, 02-202, Warszawa → Ul. Tymiankowa 24/28, 95-054, Ksawerów) | |
| 2021-12-27 | Share capital increase (5,000.00 PLN → 5,500.00 PLN) | |
| 2019-09-04 | Entered in the register |
FAQ
Last updated: 2026-10-07